Stock Earnings

Question 1

How did ALPMY's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Astellas Pharma Inc. is $24.29, beating expectations of $15.75.

Question 2

How did Astellas Pharma Inc. ALPMY's revenue perform in the last quarter?

Accepted Answer

Astellas Pharma Inc. revenue for the last quarter is $24.29

Question 3

What is the revenue estimate for Astellas Pharma Inc.?

Accepted Answer

According to 4 of Wall street analyst, the revenue estimate of Astellas Pharma Inc. range from $602.58B to $540.76B

Question 4

What's the earning quality score for Astellas Pharma Inc.?

Accepted Answer

Astellas Pharma Inc. has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Astellas Pharma Inc. report earnings?

Accepted Answer

Astellas Pharma Inc. next earnings report is expected in 2026-07-26

Question 6

What are Astellas Pharma Inc.'s expected earnings?

Accepted Answer

Astellas Pharma Inc. expected earnings is $520.02B, according to wall-street analysts.

Question 7

Did Astellas Pharma Inc. beat earnings expectations?

Accepted Answer

Astellas Pharma Inc. recent earnings of $537.92B beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$15.75	$24.29	+54.22%	BEAT
Q3 '26	$46.38	$56.03	+20.8%	BEAT
Q2 '26	$29.14	$44.22	+51.75%	BEAT
Q1 '26	$20.22	$38.21	+88.97%	BEAT
Q4 '25	$26.37	$41.84	+58.66%	BEAT

Astellas Pharma Inc. (ALPMY) Earnings

ALPMY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Astellas Pharma, Inc.?